# A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass

> **NCT06566716** · — · RECRUITING · sponsor: **Cleo Diagnostics Ltd** · enrollment: 1000 (estimated)

## Conditions studied

- Ovarian Neoplasms

## Interventions

- **DIAGNOSTIC_TEST:** CleoDX ovarian cancer test

## Key facts

- **NCT ID:** NCT06566716
- **Lead sponsor:** Cleo Diagnostics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-06
- **Primary completion:** 2025-08
- **Final completion:** 2026-08
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06566716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06566716, "A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06566716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*